文献速递重症综合管理与镇静镇痛心脑血管急症

美国提供神经重症监护的医师专科分类

Specialty Classifications of Physicians Who Provide Neurocritical Care in the United States.
PubMed 文献 · Neurocrit Care · 2019-01-01
一句话结论美国Medicare受益人神经重症监护服务中,具有临床神经科学背景的医师仅占42.8%,不足一半。

该研究利用2009至2015年全美代表性5% Medicare受益人住院索赔数据,筛选可能危及生命、需要重症监护的神经/神经外科疾病住院。通过现行程序术语编码确定提交重症监护索赔的医师专科,并链接美国神经亚专科联合委员会(UCNS)数据判断是否为神经重症监护专科医师。在1952305名受益人中共识别99937例次至少有一次神经重症监护索赔的住院。主要分析显示,神经内科医师占索赔28.0%,神经外科医师占3.7%,UCNS认证神经重症医师占25.8%,任何临床神经科学背景医师合计占42.8%。患者县社会经济地位越高,由临床神经科学背景医师管理的可能性成比例增加;这类医师位于学术医疗中心的几率是其他重症索赔医师的2.9倍(OR 2.9;95%CI 1.1-8.1)。

要点

  • 在1952305名Medicare受益人中识别99937例次神经重症监护住院,具有临床神经科学背景的医师仅覆盖42.8%的索赔。
  • 神经内科医师占神经重症监护索赔28.0%,UCNS认证神经重症医师占25.8%,神经外科医师仅占3.7%。
  • 患者所在县社会经济地位越高,由临床神经科学背景医师管理的可能性成比例增加。
  • 临床神经科学背景医师位于学术医疗中心的几率是其他重症索赔医师的2.9倍(OR 2.9;95%CI 1.1-8.1)。

适用人群与场景

  • 2009至2015年全美代表性5% Medicare受益人住院,筛选具有潜在危及生命表现、需要重症监护的神经/神经外科疾病住院。
  • 神经重症监护服务定义为:具有合格神经/神经外科诊断的重症监护索赔,患者主要出院诊断为相关疾病,且总重症监护索赔≥3次,排除住院第一天的索赔(因多为急诊科索赔)。

诊断标准与关键阈值

  • 神经重症监护服务判定:重症监护索赔带有合格神经/神经外科诊断,患者具有相关主要出院诊断,总重症监护索赔≥3次,排除住院第一天索赔。
  • 临床神经科学背景定义:神经内科医师、神经外科医师和/或UCNS认证的神经重症监护专科医师。

研究设计与关键结果

  • 研究类型为基于全国代表性5% Medicare受益人住院索赔的描述性分析,2009至2015年,共1952305名受益人,识别99937例次至少有一次神经重症监护索赔的住院。
  • 主要分析:神经内科医师占索赔28.0%(95%CI 27.5-28.5%),神经外科医师占3.7%(95%CI 3.5-3.9%),UCNS认证神经重症医师占25.8%(95%CI 25.3-26.3%),任何临床神经科学背景医师合计占42.8%(95%CI 42.2-43.3%)。
  • 患者县社会经济地位越高,由临床神经科学背景医师管理的可能性成比例增加。
  • 临床神经科学背景医师位于学术医疗中心的几率是其他提交重症监护索赔医师的2.9倍(OR 2.9;95%CI 1.1-8.1)。

证据类型、等级与局限

  • 证据类型:基于行政索赔数据的描述性研究,使用精确置信区间报告结果。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论:在美国Medicare受益人中,具有专门临床神经科学背景的医师提供的神经重症监护服务不足一半。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: We sought to characterize the specialty classification of US physicians who provide critical care for neurological/neurosurgical disease.

METHODS: Using inpatient claims between 2009 and 2015 from a nationally representative 5% sample of Medicare beneficiaries, we selected hospitalizations for neurological/neurosurgical diseases with potential to result in life-threatening manifestations requiring critical care. Using Current Procedural Terminology® codes, we determined the medical specialty of providers submitting critical care claims, and, using National Provider Identifier numbers, we merged in data from the United Council for Neurologic Subspecialties (UCNS) to determine whether the provider was a UCNS diplomate in neurocritical care. We defined providers with a clinical neuroscience background as neurologists, neurosurgeons, and/or UCNS diplomates in neurocritical care. We defined neurocritical care service as a critical care claim with a qualifying neurological/neurosurgical diagnosis in patients with a relevant primary hospital discharge diagnosis and ≥ 3 total critical care claims, excluding claims from the first day of hospitalization since these were mostly emergency-department claims. Our findings were reported using descriptive statistics with exact confidence intervals (CI).

RESULTS: Among 1,952,305 Medicare beneficiaries, we identified 99,937 hospitalizations with at least one claim for neurocritical care. In our primary analysis, neurologists accounted for 28.0% (95% CI, 27.5-28.5%) of claims, neurosurgeons for 3.7% (95% CI, 3.5-3.9%), UCNS-certified neurointensivists for 25.8% (95% CI, 25.3-26.3%), and providers with any clinical neuroscience background for 42.8% (95% CI, 42.2-43.3%). The likelihood of management by physicians with a clinical neuroscience background increased proportionally with patients' county-level socioeconomic status and such providers were 3 times more likely to be based at an academic medical center than other physicians who billed for critical care in our sample (odds ratio, 2.9; 95% CI, 1.1-8.1).

CONCLUSIONS: Physicians with a dedicated clinical neuroscience background accounted for less than half of neurocritical care service in US Medicare beneficiaries.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Martin A, Chen ML, Chatterjee A, et al. Specialty Classifications of Physicians Who Provide Neurocritical Care in the United States. Neurocrit Care. 2019. PMID: 30155587. doi:10.1007/s12028-018-0598-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。